Writer

Kim Krieger

Kim Krieger has covered politics from Capitol Hill and energy commodities from the floor of the New York Mercantile Exchange. Her stories have exposed fraud in the California power markets and mathematical malfeasance in physics. And she knows what really goes on in the National Radio Quiet Zone. These days, Kim tells clear, compelling stories of the research at UConn. Her work connects Connecticut citizens and the press with the vast resources of their flagship public university. When not at UConn, she can be found kayaking among the beautiful Norwalk islands, digging in her garden, or occasionally enjoying the silence in the National Radio Quiet Zone.


Author Archive

Nora Berrah, professor of physics, has been named a Fellow of the AAAS. (Photo courtesy of Nora Berrah)

Two UConn Faculty Named AAAS Fellows

The two women, physics researcher Nora Berrah and dental researcher Susan Reisine, are being honored by the world’s largest general scientific society for their distinguished contributions to their respective fields.

MRI service manager Elisa Medeiros prepares a patient for functional MRI testing at the BIRC in the Phillips Communication Sciences Building. (Peter Morenus/UConn Photo)

UConn Health Patients Can Now Get MRIs at UConn in Storrs

Thanks to a collaboration between UConn Health physicians and UConn researchers, sophisticated MRI scanning equipment originally purchased for research use will now be used for diagnosing patients of UConn Health in Storrs.

A special team of medical literature experts are on the hunt for cancer's kryptonite, one mutation at a time. (Kailey Whitman Illustration for UConn)

Curators Versus Cancer

A special team of medical literature experts are on the hunt for cancer's kryptonite, one mutation at a time.

John Salamone, Board of Trustees Distinguished Professor of Psychology, in the lab at the Bousfield Building. (Peter Morenus/UConn File Photo)

Moving the Motivation Meter

UConn researchers led by behavioral neuroscientist John Salamone have found that two experimental drugs boost motivation in rats, pointing the way to potential treatments.

Conceptual image of salmonella typhi causing typhoid. (Getty Images)

T Cells That Stay Put Could Be Key to a Better Salmonella Vaccine

UConn and UC Davis researchers announced a breakthrough in understanding which cells protect against Salmonella – a critical step in developing a better vaccine against the often deadly bacterium.

An illustration showing THC binding to cannabinoid receptors. Tetrahydrocannabinol (THC, green molecules) is the main psychoactive constituent of cannabis. (Getty Images)

The Blitz of Neuroscience

UConn neuroscience researchers from across departments and campuses came together this week for a "datablitz," where several graduate students presented fast-moving summaries of their research to a live audience.

Suicide Risk Higher Among Older Vets Who Were in Jail

Veterans released from prison are five times as likely to attempt suicide as their peers who have never been incarcerated, according to a study by UConn Health researchers.

Digitalis lanata, the woolly foxglove, is the source of digoxin, a medication long used to treat heart conditions that has now been found to have potential for treating medulloblastoma, the most common malignant brain tumor in children. (Michael Wolf via Wikimedia Commons)

Old Drug, New Hope for Pediatric Brain Cancer

Researchers from JAX, Connecticut Children's Hospital, and UConn Health have identified several drugs used against other diseases that also have the potential to fight the most common form of childhood brain cancer.

The bacteria Mycobacterium tuberculosis. The molecule (inset) shows the active part of the peptide, the section that binds copper. (Image courtesy of Alfredo Angeles-Boza Lab)

A Copper Bullet for Tuberculosis

In a new study, UConn chemists report a new antibiotic that can find and kill tuberculosis bacteria where they hide.

A human fetus in utero. (Getty Images)

Calm the Immune System, Halt Premature Birth

UConn Health researchers found that a drug that blocks the cytokine GM-CSF may reduce the number of preterm births.